Caberlee 0.5mg

Price 50 INR/ Unit

Get a Price/Quote

MOQ : 10000 Units

Caberlee 0.5mg Specification

Physical Form
Tablets

Dosage
0.5MG

Dosage Guidelines
As per physician

Storage Instructions
Keep Dry Place

Caberlee 0.5mg Trade Information

Minimum Order Quantity
10000 Units

Delivery Time
1 Week

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

About Caberlee 0.5mg

Caberlee 0.5mg - Cabergoline is a medication primarily used to treat high levels of prolactin hormone in the body (hyperprolactinemia). It belongs to a class of medications known as dopamine agonists. Cabergoline works by mimicking the action of dopamine, a neurotransmitter in the brain that regulates hormone secretion from the pituitary gland.

Here are some key points about Caberlee 0.5mg- cabergoline tablets:

Indications: Cabergoline is commonly prescribed to treat conditions such as hyperprolactinemia, which can cause symptoms like irregular menstrual periods, infertility, and unwanted breast milk production (galactorrhea). Its also sometimes used to treat prolactinomas, which are benign tumors of the pituitary gland that produce prolactin.

Dosage: The dosage of cabergoline can vary depending on the condition being treated and individual patient factors. Its typically taken orally, and the dosage may be adjusted by a healthcare provider based on the patients response to treatment and any side effects experienced.

Side Effects: Like any medication, cabergoline can cause side effects. Common side effects may include nausea, dizziness, headache, fatigue, and constipation. In some cases, it can also cause more serious side effects such as low blood pressure, hallucinations, and problems with heart valve function. Its important for patients to report any unusual symptoms to their healthcare provider.

Precautions: Cabergoline may not be suitable for everyone, particularly those with certain medical conditions or those taking certain medications. Its important for patients to discuss their medical history and any other medications they are taking with their healthcare provider before starting cabergoline.

Monitoring: Patients taking cabergoline may require regular monitoring of prolactin levels and other blood tests to assess their response to treatment and monitor for any potential side effects.

Pregnancy and Breastfeeding: Cabergoline is generally not recommended during pregnancy or breastfeeding unless the potential benefits outweigh the risks. It can cross the placenta and may harm the developing fetus, and its also excreted in breast milk.

Interactions: Cabergoline may interact with other medications, including certain antidepressants and medications that affect blood pressure. Its important for patients to inform their healthcare provider about all medications they are taking to avoid potential interactions.